Advertisement

Supply Chain

The U.S. Food and Drug Administration has approved a Supplemental New Drug Application for Bristol-Myers Squibb/Pfizer's Eliquis (apixaban) as a preventative measure against potential pulmonary embolism-causing blood clots for patients who have undergone hip or knee replacement therapy, according to…

Dublin, Ireland-based Shire Pharmaceuticals has issued a voluntary recall on three lots of VPRIV, a long-term intravenous enzyme replacement therapy for patients with type 1 Gaucher disease, due to stainless steel and barium sulfate particulate matter found in a few…

Advertisement

The U.S. Food and Drug Administration approved Herstal, Belgium-based STX-Med to market Cefaly, the first medical device offering preventative treatment for migraines.

Phoenix-based SharedClarity, a subsidiary of Minneapolis-based UnitedHealth Group, has signed agreements with Medtronic and Abbott Laboratories to buy the majority of its heart stents from the device companies at highly discounted prices for its 135 network hospitals, according to a…

Advertisement